XML 50 R41.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Entities and Acquisitions - Pro Forma Information (Details) - Entasis Therapeutics Holdings Inc - La Jolla Pharmaceutical Company - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Business Acquisition [Line Items]        
Revenue $ 72,830 $ 111,176 $ 292,077 $ 347,696
Net income 221,473 45,109 266,797 183,252
Net income attributable to Innoviva stockholders $ 272,797 $ 19,892 $ 276,200 $ 129,803